Thyroid Cancer

Thyroid Cancer is cancer that forms in the thyroid gland (an organ at the base of the throat that makes hormones that help control heart rate, blood pressure, body temperature, and weight). Four main types of thyroid cancer are papillary, follicular, medullary, and anaplastic thyroid cancer. The four types are based on how the cancer cells look under a microscope.

What is Thyroid Cancer?

Thyroid cancer is a type of cancer involving unregulated cell growth in the thyroid gland, which is located at the base of the neck. It is a rare type of cancer, accounting for approximately 1% of all people diagnosed with cancer.

Thyroid Cancer Symptoms

Thyroid Cancer Treatments

Hürthle Cell Thyroid Cancer

Exposure to nighttime artificial lights linked with higher risk of thyroid cancer

People living in regions with high levels of outdoor artificial light at night may face a higher risk of developing thyroid cancer.

8 Feb 2021

SU2C announces $3.25 million in grants to find new treatments for head and neck cancers

Stand Up To Cancer today announced $3.25 million in grants from four national nonprofits to fund research to find new treatments for head and neck cancers, which are newly diagnosed in about 65,000 Americans every year.

21 Jan 2021

New computational technique accurately differentiates between data from tumor cells and normal cells

In an effort to address a major challenge when analyzing large single-cell RNA-sequencing datasets, researchers from The University of Texas MD Anderson Cancer Center have developed a new computational technique to accurately differentiate between data from cancer cells and the variety of normal cells found within tumor samples.

18 Jan 2021

Thyroid cancer linked to in-utero exposures, study shows

A recent study by prof. Tone Bjørge, University of Bergen, and her team shows that thyroid cancer is related to in-utero exposures.

5 Jan 2021

Active surveillance could be a viable treatment option for patients with low-risk thyroid cancer

Results from a new study co-led by researchers at Dartmouth's Geisel School of Medicine and the Department of Surgery at Kuma Hospital in Kobe, Japan show that active surveillance can be successfully implemented as a viable treatment option for patients with low-risk thyroid cancer.

8 Dec 2020

Targeted therapy found to be effective at shrinking tumors in patients with nonsmall-cell lung cancer

An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations in the gene RET, was effective at shrinking tumours in patients with nonsmall cell lung cancer (NSCLC), with a majority of patients living for more than a year without disease progression.

28 Sep 2020

Targeted therapy achieves durable objective responses Phase I/II LIBRETTO-001 trial

For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted therapy selpercatinib was well tolerated and achieved durable objective responses, or tumor shrinkage, in the majority of participants in the Phase I/II LIBRETTO-001 trial, according to researchers from The University of Texas MD Anderson Cancer Center.

27 Aug 2020

Sortilin may hold the key to developing more effective treatment for pancreatic cancer

Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States.

20 Aug 2020

Combination therapy effective for patients with cholangiocarcinoma marked by BRAF mutations

In a Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center, the combination of dabrafenib, a BRAF inhibitor, and trametinib, a MEK inhibitor, achieved a 51% overall response rate (ORR) in patients with cholangiocarcinoma marked by the BRAF V600E mutation.

18 Aug 2020

Study uses a statistical approach to reveal patterns of cancer incidence

QUT researchers have used nationwide cancer mapping statistics to develop a new mathematical model so health professionals can further question patterns relating to the disease.

13 Aug 2020

Physicians report misuse of thyroid tests for unsupported reasons

Up to one-third of physicians reported sending patients for a thyroid ultrasound for reasons not supported by clinical care guidelines, a new study led by University of Michigan Rogel Cancer Center researchers finds.

12 Aug 2020

Genes associated with SARS-CoV-2 human lung cell infection

Now, a new study published on the preprint server bioRxiv in June 2020 attempts to make sense of this data to identify viral genes that are explicitly expressed in the cells infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This could help reveal new therapeutic targets.

26 Jun 2020

Accelerating the Diagnosis and Treatment of Cancer with Mass-Spectrometry Based Techniques

An interview with Livia Eberlin, Assistant Professor at the University of Texas at Austin, discussing the development of mass-spectrometry based techniques for cancer diagnosis and improved clinical outcomes.

From Pittcon 16 Jun 2020

Study investigates combined effects of cancer therapy and inherited genetics

Scientists at St. Jude Children's Research Hospital are studying the combined effect of cancer treatments and inherited mutations in DNA-repair genes.

5 Jun 2020

KinaRx receives SBIR grant to speed up clinical trials for AML and other diseases

Acute myeloid leukemia (AML), an aggressive blood cancer, is one of the most lethal cancers. More than 19,000 new cases are diagnosed a year, and more than 11,000 people a year die from it, according to the American Cancer Society.

3 Jun 2020

Mini tumors predict how cancer responds to heat treatment

Hyperthermia has shown promise in the treatment of cancer in previous studies. Now, in a new study by scientists at The Institute of Cancer Research, London, the researchers tested the effects of a combination of heat and radiation on mini tumors grown in a spheroid, where cells are placed in a three-dimensional structure. The research is published in the journal Scientific Reports.

3 Jun 2020

Targeted therapy pralsetinib shows high response rates in patients with RET fusion-positive cancers

The targeted therapy pralsetinib appears to have high response rates and durable activity in patients with a broad variety of tumors harboring RET gene fusions, according to results from the international Phase I/II ARROW trial, led by researchers at The University of Texas MD Anderson Cancer Center.

29 May 2020

Thyroid Cancer

Overview

Thyroid Cancer Symptoms

Thyroid Cancer Treatments

Hürthle Cell Thyroid Cancer

Latest Thyroid Cancer News and Research

Exposure to nighttime artificial lights linked with higher risk of thyroid cancer

SU2C announces $3.25 million in grants to find new treatments for head and neck cancers

New computational technique accurately differentiates between data from tumor cells and normal cells

Thyroid cancer linked to in-utero exposures, study shows

Active surveillance could be a viable treatment option for patients with low-risk thyroid cancer

Targeted therapy found to be effective at shrinking tumors in patients with nonsmall-cell lung cancer

Targeted therapy achieves durable objective responses Phase I/II LIBRETTO-001 trial

Sortilin may hold the key to developing more effective treatment for pancreatic cancer

Combination therapy effective for patients with cholangiocarcinoma marked by BRAF mutations

Study uses a statistical approach to reveal patterns of cancer incidence

Physicians report misuse of thyroid tests for unsupported reasons

Genes associated with SARS-CoV-2 human lung cell infection

Accelerating the Diagnosis and Treatment of Cancer with Mass-Spectrometry Based Techniques

Study investigates combined effects of cancer therapy and inherited genetics

KinaRx receives SBIR grant to speed up clinical trials for AML and other diseases

Mini tumors predict how cancer responds to heat treatment

Targeted therapy pralsetinib shows high response rates in patients with RET fusion-positive cancers

Working too many hours may lead to an underactive thyroid

Research shows significant difference in radiation response between sexes

Aggressive features in papillary thyroid microcarcinoma raises the risk for distant metastasis

Could a diet high in carbohydrates increase your risk of heart disease?

What makes viruses infectious?

Disinfectants could be helping bacteria to become resistant

Thyroid Cancer

Overview

Latest Thyroid Cancer News and Research

Newsletters you may be interested in